{"entity":{"type":"insider","cik":"0001863418","url":"/insider/0001863418","json_url":"/insider/0001863418.json","name":"Bush Tia L","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":10,"first":"2021-06-04","last":"2025-11-18","span_basis":"filed_date"},"name_variants":[{"name":"Bush Tia L","source":"filing","n_filings":10,"first_seen":"2021-06-04","last_seen":"2025-11-18"}],"transactions":[{"id":4287284,"accession":"0001470831-25-000343","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001470831-25-000343","line_url":"/filing/0001470831-25-000343#line-2","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001863418","owner_name":"Bush Tia L","owner_display_name":"Bush Tia L","owner_url":"/insider/0001863418","role":"Officer (Chief Technology & Quality Ofc)","role_mark":"O","role_mark_label":"Officer (Chief Technology & Quality Ofc)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology & Quality Ofc","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":28.0,"price_display":"28.00","price_state":"stated","total_value":1120000.0,"total_display":"1,120,000.00","total_whole":"1,120,000","shares_owned_after":121503.0,"shares_owned_after_display":"121,503","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-17","filed_date":"2025-11-18","scope":"insider"},{"id":4080148,"accession":"0001470831-25-000315","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001470831-25-000315","line_url":"/filing/0001470831-25-000315#line-2","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001863418","owner_name":"Bush Tia L","owner_display_name":"Bush Tia L","owner_url":"/insider/0001863418","role":"Officer (Chief Technology & Quality Ofc)","role_mark":"O","role_mark_label":"Officer (Chief Technology & Quality Ofc)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology & Quality Ofc","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":26.0,"price_display":"26.00","price_state":"stated","total_value":1040000.0,"total_display":"1,040,000.00","total_whole":"1,040,000","shares_owned_after":121503.0,"shares_owned_after_display":"121,503","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-12","filed_date":"2025-11-13","scope":"insider"},{"id":4256730,"accession":"0001470831-25-000225","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001470831-25-000225","line_url":"/filing/0001470831-25-000225#line-2","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001863418","owner_name":"Bush Tia L","owner_display_name":"Bush Tia L","owner_url":"/insider/0001863418","role":"Officer (Chief Technology & Quality Ofc)","role_mark":"O","role_mark_label":"Officer (Chief Technology & Quality Ofc)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology & Quality Ofc","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35000.0,"shares_display":"35,000","price_per_share":24.0,"price_display":"24.00","price_state":"stated","total_value":840000.0,"total_display":"840,000.00","total_whole":"840,000","shares_owned_after":121503.0,"shares_owned_after_display":"121,503","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-24","filed_date":"2025-09-24","scope":"insider"},{"id":4287270,"accession":"0001470831-25-000192","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001470831-25-000192","line_url":"/filing/0001470831-25-000192#line-4","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001863418","owner_name":"Bush Tia L","owner_display_name":"Bush Tia L","owner_url":"/insider/0001863418","role":"Officer (Chief Technology & Quality Ofc)","role_mark":"O","role_mark_label":"Officer (Chief Technology & Quality Ofc)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology & Quality Ofc","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":22.0,"price_display":"22.00","price_state":"stated","total_value":550000.0,"total_display":"550,000.00","total_whole":"550,000","shares_owned_after":121503.0,"shares_owned_after_display":"121,503","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-10","filed_date":"2025-09-11","scope":"insider"},{"id":4287264,"accession":"0001470831-25-000192","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001470831-25-000192","line_url":"/filing/0001470831-25-000192#line-2","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001863418","owner_name":"Bush Tia L","owner_display_name":"Bush Tia L","owner_url":"/insider/0001863418","role":"Officer (Chief Technology & Quality Ofc)","role_mark":"O","role_mark_label":"Officer (Chief Technology & Quality Ofc)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology & Quality Ofc","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24792.0,"shares_display":"24,792","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":495840.0,"total_display":"495,840.00","total_whole":"495,840","shares_owned_after":121503.0,"shares_owned_after_display":"121,503","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-09","filed_date":"2025-09-11","scope":"insider"},{"id":4323481,"accession":"0001847903-25-000023","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001847903-25-000023","line_url":"/filing/0001847903-25-000023#line-2","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001863418","owner_name":"Bush Tia L","owner_display_name":"Bush Tia L","owner_url":"/insider/0001863418","role":"Officer (Chief Technology & Quality Ofc)","role_mark":"O","role_mark_label":"Officer (Chief Technology & Quality Ofc)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology & Quality Ofc","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11000.0,"shares_display":"11,000","price_per_share":16.8551,"price_display":"16.86","price_state":"stated","total_value":185406.1,"total_display":"185,406.10","total_whole":"185,406","shares_owned_after":121503.0,"shares_owned_after_display":"121,503","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-03","filed_date":"2025-02-04","scope":"insider"},{"id":2809766,"accession":"0001847903-24-000184","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001847903-24-000184","line_url":"/filing/0001847903-24-000184#line-3","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001863418","owner_name":"Bush Tia L","owner_display_name":"Bush Tia L","owner_url":"/insider/0001863418","role":"Officer (Chief Technology & Quality Ofc)","role_mark":"O","role_mark_label":"Officer (Chief Technology & Quality Ofc)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology & Quality Ofc","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17813.0,"shares_display":"17,813","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":320634.0,"total_display":"320,634.00","total_whole":"320,634","shares_owned_after":147615.0,"shares_owned_after_display":"147,615","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-17","filed_date":"2024-12-17","scope":"insider"},{"id":2809755,"accession":"0001847903-24-000184","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001847903-24-000184","line_url":"/filing/0001847903-24-000184#line-1","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001863418","owner_name":"Bush Tia L","owner_display_name":"Bush Tia L","owner_url":"/insider/0001863418","role":"Officer (Chief Technology & Quality Ofc)","role_mark":"O","role_mark_label":"Officer (Chief Technology & Quality Ofc)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology & Quality Ofc","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9611.0,"shares_display":"9,611","price_per_share":16.3621,"price_display":"16.36","price_state":"stated","total_value":157256.1431,"total_display":"157,256.14","total_whole":"157,256","shares_owned_after":147615.0,"shares_owned_after_display":"147,615","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-16","filed_date":"2024-12-17","scope":"insider"},{"id":8418192,"accession":"0001847903-23-000102","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001847903-23-000102","line_url":"/filing/0001847903-23-000102","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001863418","owner_name":"Bush Tia L","owner_display_name":"Bush Tia L","owner_url":"/insider/0001863418","role":"Officer (Chief Quality Officer)","role_mark":"O","role_mark_label":"Officer (Chief Quality Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Quality Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":4.4831625,"price_display":"4.48","price_state":"stated","total_value":35865.3,"total_display":"35,865.30","total_whole":"35,865","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-24","filed_date":"2023-05-26","scope":"insider","n_lines":2},{"id":6735075,"accession":"0001847903-22-000062","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001847903-22-000062","line_url":"/filing/0001847903-22-000062#line-2","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001863418","owner_name":"Bush Tia L","owner_display_name":"Bush Tia L","owner_url":"/insider/0001863418","role":"Officer (Chief Quality Officer)","role_mark":"O","role_mark_label":"Officer (Chief Quality Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Quality Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2595.0,"shares_display":"2,595","price_per_share":3.9501,"price_display":"3.95","price_state":"stated","total_value":10250.5095,"total_display":"10,250.51","total_whole":"10,251","shares_owned_after":135287.0,"shares_owned_after_display":"135,287","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-03","filed_date":"2022-10-04","scope":"insider"},{"id":6735071,"accession":"0001847903-22-000062","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001847903-22-000062","line_url":"/filing/0001847903-22-000062#line-1","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001863418","owner_name":"Bush Tia L","owner_display_name":"Bush Tia L","owner_url":"/insider/0001863418","role":"Officer (Chief Quality Officer)","role_mark":"O","role_mark_label":"Officer (Chief Quality Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Quality Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2118.0,"shares_display":"2,118","price_per_share":4.0674,"price_display":"4.07","price_state":"stated","total_value":8614.7532,"total_display":"8,614.75","total_whole":"8,615","shares_owned_after":137882.0,"shares_owned_after_display":"137,882","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-30","filed_date":"2022-10-04","scope":"insider"},{"id":5088033,"accession":"0000899243-21-045312","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-045312","line_url":"/filing/0000899243-21-045312","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001863418","owner_name":"Bush Tia L","owner_display_name":"Bush Tia L","owner_url":"/insider/0001863418","role":"Officer (Chief Quality Officer)","role_mark":"O","role_mark_label":"Officer (Chief Quality Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Quality Officer","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":12.46045,"price_display":"12.46","price_state":"stated","total_value":62302.25,"total_display":"62,302.25","total_whole":"62,302","shares_owned_after":8000.0,"shares_owned_after_display":"8,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-16","filed_date":"2021-11-18","scope":"insider","n_lines":2},{"id":4974569,"accession":"0000899243-21-022069","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-022069","line_url":"/filing/0000899243-21-022069#line-1","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001863418","owner_name":"Bush Tia L","owner_display_name":"Bush Tia L","owner_url":"/insider/0001863418","role":"Officer (Chief Quality Officer)","role_mark":"O","role_mark_label":"Officer (Chief Quality Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Quality Officer","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":60000.0,"total_display":"60,000.00","total_whole":"60,000","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-02","filed_date":"2021-06-04","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001847903","name":"Centessa Pharmaceuticals plc","url":"/issuer/0001847903","role":"Officer (Chief Technology & Quality Ofc)","n_filings":10,"first_seen":"2021-06-04","last_seen":"2025-11-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001863418","retrieved_at":"2026-08-22T06:52:04+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}